Get the Stockscreener App
0.4259
3.41%
-0.0232
Applied Therapeutics Inc Stock (APLT) Forecast
The Applied Therapeutics Inc (APLT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $23.78, representing a +5,483% increase from the current price of $0.4259. The highest analyst price target is $28.52, and the lowest is $19.03.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month APLT Price Target
Average 18.72
(+4,296% Upside)
Is Applied Therapeutics Inc (APLT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 49.72 | Neutral |
| STOCH(9,6) | 38.89 | Neutral |
| STOCHRSI(14) | 9.5611 | Buy |
| MACD(12,26) | 0.00885 | Sell |
| ADX(14) | 11.40 | Neutral |
| William %R | -74.56 | Neutral |
| CCI(14) | -57.31 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.4454
Sell
|
0.4461
Sell
|
| MA20 |
0.4608
Sell
|
0.4428
Sell
|
| MA50 |
0.4017
Buy
|
0.4341
Buy
|
| MA100 |
0.4121
Buy
|
0.6617
Sell
|
| MA200 |
1.6905
Sell
|
1.6286
Sell
|
Buy: 3
Sell: 7
Neutral: 0
Summary: Sell
According to our latest analysis, APLT could be considered a Moderate Sell, with 17 technical analysis indicators signaling 4 Buy signals, 8 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on APLT, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 49.72 indicates that APLT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 38.89 indicates that APLT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 9.5611 indicates that APLT is oversold. This suggests that APLT price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 11.4 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -57.31 indicates that APLT is still oversold but not to an extreme extent.
Long-term APLT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Applied Therapeutics Inc financial reports and earnings history, Applied Therapeutics Inc (APLT) stock could reach $2.1667 by 2030, $7.5949 by 2040 and $16.70 by 2050. See the projected annual prices until 2050 of the Applied Therapeutics Inc stock below:
- Applied Therapeutics Inc (APLT) is expected to reach an average price of $3.0766 in 2035, with a high prediction of $3.4291 and a low estimate of $3.4026. This indicates an $622.39% rise from the last recorded price of $0.4259.
- Applied Therapeutics Inc (APLT) stock is projected to chart a bullish course in 2040, with an average price target of $7.8049, representing an $1,733% surge from its current level. The forecast ranges from a conservative $7.9085 to a sky-high $7.5949.
- Our analysts predict Applied Therapeutics Inc (APLT) to jump 2,947% by 2045, soaring from $13.05 to an average price of $12.98, potentially reaching $13.18. While $13.05 is the low estimate, the potential upside is significant.
- Applied Therapeutics Inc (APLT) stock is expected to climb by 2050, reaching an average of $16.83, a $3,851% jump from its current level. However, a wide range of estimates exists, with high and low targets of $16.70 and $16.64, respectively, highlighting the market's uncertainty.
Applied Therapeutics Inc Stock (APLT) Year by Year Forecast
Applied Therapeutics Inc Stock (APLT) Price Forecast for 2025
Applied Therapeutics Inc Stock (APLT) is expected to reach an average price of $31.59 in 2025, with a high prediction of $52.26 and a low estimate of $10.93. This indicates an +7,318% rise from the last recorded price of $0.4259.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| September, 2025 | $24.41 | $19.03 | $28.52 | +5,631% |
| October, 2025 | $19.50 | $17.53 | $23.97 | +4,478% |
| November, 2025 | $15.30 | $14.07 | $22.44 | +3,492% |
| December, 2025 | $11.83 | $10.93 | $19.79 | +2,678% |
Applied Therapeutics Inc Stock (APLT) Price Forecast for 2026
The predicted value for Applied Therapeutics Inc (APLT) in 2026 is set at an average of $17.10. Estimates vary from a peak of $25.29 to a trough of $8.9024, indicating an +3,914% surge from the present price of $0.4259.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $18.66 | $8.9227 | $19.90 | +4,282% |
| February, 2026 | $17.72 | $14.68 | $21.90 | +4,060% |
| March, 2026 | $15.19 | $14.78 | $19.59 | +3,466% |
| April, 2026 | $17.23 | $14.98 | $25.29 | +3,946% |
| May, 2026 | $15.40 | $11.77 | $18.32 | +3,517% |
| June, 2026 | $11.99 | $11.69 | $15.72 | +2,715% |
| July, 2026 | $12.76 | $9.3502 | $15.22 | +2,896% |
| August, 2026 | $18.13 | $12.37 | $20.11 | +4,157% |
| September, 2026 | $15.35 | $14.83 | $21.29 | +3,503% |
| October, 2026 | $11.85 | $10.96 | $16.70 | +2,682% |
| November, 2026 | $11.75 | $9.4793 | $14.81 | +2,659% |
| December, 2026 | $13.54 | $8.9024 | $13.66 | +3,080% |
Applied Therapeutics Inc Stock (APLT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Applied Therapeutics Inc (APLT) is $7.5687, with a high forecast of $15.04 and a low forecast of $0.0926. This indicates an +1,677% increase from the last price of $0.4259.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $10.66 | $9.3254 | $15.04 | +2,402% |
| February, 2027 | $6.8484 | $6.1884 | $12.34 | +1,508% |
| March, 2027 | $5.8614 | $4.7708 | $7.8596 | +1,276% |
| April, 2027 | $0.7661 | $0.0926 | $5.942 | +79.89% |
| May, 2027 | $1.5637 | $1.2655 | $1.0937 | +267.16% |
| June, 2027 | $2.2507 | $1.7831 | $1.9707 | +428.46% |
| July, 2027 | $1.5183 | $1.6483 | $1.7701 | +256.48% |
| August, 2027 | $1.7858 | $1.4877 | $1.6958 | +319.31% |
| September, 2027 | $2.2628 | $1.9952 | $2.1334 | +431.30% |
| October, 2027 | $2.8151 | $2.5121 | $2.4604 | +560.98% |
| November, 2027 | $2.588 | $2.7171 | $2.6993 | +507.65% |
| December, 2027 | $2.0849 | $2.2949 | $2.5429 | +389.54% |
Applied Therapeutics Inc Stock (APLT) Price Forecast for 2028
In 2028, Applied Therapeutics Inc (APLT) is projected to reach an average price of $2.2205, with a high projection of $2.7715 and a low estimate of $1.6695. This indicates an +421.37% rise from the last price of $0.4259.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.0625 | $2.2137 | $2.1131 | +384.27% |
| February, 2028 | $2.86 | $2.1819 | $2.4709 | +571.52% |
| March, 2028 | $2.7002 | $2.7078 | $2.7715 | +533.99% |
| April, 2028 | $2.2647 | $2.5347 | $2.5265 | +431.73% |
| May, 2028 | $2.5716 | $2.499 | $2.5016 | +503.81% |
| June, 2028 | $2.0792 | $2.2592 | $2.371 | +388.19% |
| July, 2028 | $2.2268 | $2.1979 | $2.1174 | +422.84% |
| August, 2028 | $2.2416 | $2.2645 | $2.2338 | +426.31% |
| September, 2028 | $2.3153 | $2.3905 | $2.3125 | +443.63% |
| October, 2028 | $1.5189 | $1.6695 | $2.1508 | +256.63% |
| November, 2028 | $1.5959 | $1.7183 | $1.7056 | +274.71% |
| December, 2028 | $1.6535 | $1.6747 | $1.6235 | +288.23% |
Applied Therapeutics Inc Stock (APLT) Price Forecast for 2029
The 2029 price forecast for Applied Therapeutics Inc Stock (APLT) is $3.3959 on average, with a high prediction of $6.7902 and a low estimate of $0.00166. This represents an +697.35% increase from the previous price of $0.4259.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.1804 | $1.3161 | $1.5649 | +177.16% |
| February, 2029 | $1.588 | $1.537 | $1.478 | +272.86% |
| March, 2029 | $0.1756 | $1.0356 | $1.5673 | -58.77% |
| April, 2029 | $0.3332 | $0.5032 | $0.3038 | -21.77% |
| May, 2029 | $0.7901 | $0.3834 | $0.5401 | +85.52% |
| June, 2029 | $0.3723 | $0.5177 | $0.6595 | -12.59% |
| July, 2029 | $0.4453 | $0.0471 | $1.7247 | +4.55% |
| August, 2029 | $0.3777 | $0.1534 | $0.5671 | -11.31% |
| September, 2029 | $4.5202 | $0.00166 | $6.7902 | +961.32% |
| October, 2029 | $4.2532 | $2.792 | $5.1278 | +898.63% |
| November, 2029 | $1.7756 | $1.6606 | $4.1638 | +316.91% |
| December, 2029 | $1.1288 | $1.4488 | $2.1968 | +165.04% |
Applied Therapeutics Inc Stock (APLT) Price Forecast for 2030
Applied Therapeutics Inc Stock (APLT) is expected to reach an average price of $23.86 in 2030, with a high forecast of $47.12 and a low forecast of $0.5909. This signifies an +5,501% surge from the last price of $0.4259.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2.7927 | $1.3676 | $2.1667 | +555.73% |
| February, 2030 | $2.1979 | $2.3879 | $2.1625 | +416.06% |
| March, 2030 | $1.123 | $2.3104 | $1.5855 | +163.69% |
| April, 2030 | $1.4332 | $1.3206 | $0.8318 | +236.51% |
| May, 2030 | $0.0279 | $0.7521 | $0.7942 | -93.46% |
| June, 2030 | $6.3827 | $0.5909 | $9.8303 | +1,399% |
| July, 2030 | $10.79 | $3.4951 | $15.72 | +2,433% |
| August, 2030 | $16.85 | $8.04 | $18.33 | +3,857% |
| September, 2030 | $38.07 | $13.65 | $42.85 | +8,838% |
| October, 2030 | $29.81 | $27.81 | $47.12 | +6,899% |
| November, 2030 | $20.37 | $8.3181 | $34.60 | +4,683% |
| December, 2030 | $32.96 | $18.50 | $37.94 | +7,640% |
0.66%
2.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):